Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

NCT ID: NCT03242642

This clinical trial is studying a new device called the Medtronic Intrepid™ that is designed to help patients with a serious heart condition known as mitral valve regurgitation. In this condition, ...

Recruiting

Phase: NA Conditions: Mitral Valve Regurgitation

Two Dose Levels of Privigen in Pediatric CIDP

NCT ID: NCT03684018

This clinical trial, titled “Two Dose Levels of Privigen in Pediatric CIDP,” is studying the effects of a medication called Privigen on children and teenagers aged 2 to 17 who have been diagnosed w...

Recruiting

Phase: PHASE4 Conditions: Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT ID: NCT03866382

This clinical trial is investigating how well three medications—cabozantinib, nivolumab, and ipilimumab—work together to treat patients with rare genitourinary tumors that have spread to other part...

Recruiting

Phase: PHASE2 Conditions: Stage IVB Prostate Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 +43 more

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

NCT ID: NCT04267848

The ALCHEMIST trial is a clinical study looking at whether adding a drug called pembrolizumab, which is a type of immunotherapy, to standard chemotherapy can improve treatment outcomes for patients...

Recruiting

Phase: PHASE3 Conditions: Stage IIIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 +4 more

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

NCT ID: NCT04649242

This clinical trial is looking at a new treatment called BHV-3000 for children and teenagers who suffer from moderate or severe migraines. The study aims to see if this medication is safe and effec...

Recruiting

Phase: PHASE3 Conditions: Pediatric Migraine

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

NCT ID: NCT04905693

RIN-PF-302 is a long-term safety study of inhaled treprostinil for people with idiopathic pulmonary fibrosis (IPF), a type of interstitial lung disease. It’s an open-label extension, meaning all pa...

Enrolling by invitation

Phase: PHASE3 Conditions: Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

NCT ID: NCT05058651

This clinical trial is studying the effects of a new immunotherapy drug called atezolizumab when combined with standard chemotherapy for patients with advanced or metastatic neuroendocrine carcinom...

Recruiting

Phase: PHASE2 Conditions: Recurrent Extrapulmonary Neuroendocrine Carcinoma, Unresectable Extrapulmonary Neuroendocrine Carcinoma +2 more

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

NCT ID: NCT05099003

This clinical trial is studying a new drug called selinexor, which is being tested in combination with standard radiation therapy to treat children and young adults with newly diagnosed brain tumor...

Recruiting

Phase: PHASE1 Conditions: Malignant Glioma

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

NCT ID: NCT05138133

This clinical trial is studying a medication called Anifrolumab to see how well it works and how safe it is for adults who have a type of kidney inflammation caused by lupus, known as active prolif...

Recruiting

Phase: PHASE3 Conditions: Lupus Nephritis

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

NCT ID: NCT05636176

This clinical trial is studying a new treatment called ziltivekimab for people with heart failure who also have inflammation. Heart failure means the heart isn't pumping blood as well as it should,...

Recruiting

Phase: PHASE3 Conditions: Heart Failure

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

NCT ID: NCT06118281

The ARTEMIS clinical trial is investigating a new medication called ziltivekimab, which researchers hope can help people who have recently had a heart attack. The goal is to see if ziltivekimab can...

Recruiting

Phase: PHASE3 Conditions: Cardiovascular Risk, Acute Myocardial Infarction (AMI)

A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

NCT ID: NCT06223360

The BenfoTeam trial is studying a medication called Benfotiamine to see if it can help slow down the symptoms of early Alzheimer's disease. This study is specifically looking at people aged 50 to 8...

Recruiting

Phase: PHASE2 Conditions: Alzheimer Disease

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

NCT ID: NCT06516965

This clinical trial, called STOP-PN2, is studying a medication called povorcitinib to see how well it works for people with prurigo nodularis, a skin condition that causes severe itching and bumps ...

Recruiting

Phase: PHASE3 Conditions: Prurigo Nodularis

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NCT ID: NCT06548360

This clinical trial is studying a new cream called ruxolitinib to see if it is safe and effective for children with nonsegmental vitiligo, a condition where patches of skin lose their color. The tr...

Recruiting

Phase: PHASE3 Conditions: NonSegmental Vitiligo

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

NCT ID: NCT06551324

This clinical trial, called MEVPRO-1, is looking at a new medicine called PF-06821497 (Mevrometostat) to see if it can help men with metastatic castrate-resistant prostate cancer (mCRPC) who have p...

Recruiting

Phase: PHASE3 Conditions: Metastatic Castrate Resistant Prostate Cancer (mCRPC)

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

NCT ID: NCT06629779

This clinical trial is studying a new drug called PF-06821497 (also known as Mevrometostat) to see if it works better when combined with another medication called enzalutamide for men with metastat...

Recruiting

Phase: PHASE3 Conditions: Metastatic Castration-Resistant Prostate Cancer

Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism

NCT ID: NCT06690294

This clinical trial is looking at how experiences from childhood can affect how adults eat and manage their weight. Researchers want to understand if certain life events during childhood influence ...

Not yet recruiting

Conditions: Healthy Volunteer, Obestity

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

NCT ID: NCT06830798

This clinical trial is studying a medication called ravulizumab to see if it can help people who are at high risk of experiencing Delayed Graft Function (DGF) after receiving a kidney transplant. D...

Recruiting

Phase: PHASE3 Conditions: Kidney Transplant, Delayed Graft Function +1 more

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

NCT ID: NCT06832618

This clinical trial is looking at a new cream called ruxolitinib to see if it is effective and safe for children and teenagers aged 6 to under 18 who have moderate atopic dermatitis, which is a typ...

Recruiting

Phase: PHASE3 Conditions: Atopic Dermatitis

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

NCT ID: NCT06855498

This clinical trial is a continuation study for people who have already participated in earlier studies involving a medication called povorcitinib, which is being tested for a skin condition known ...

Recruiting

Phase: PHASE3 Conditions: Hidradenitis Suppurativa (HS)

Main Menu

Clinical Trials in Phoenix, Arizona

969 Active Trials Found in Phoenix

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Two Dose Levels of Privigen in Pediatric CIDP

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib